Brazilian guideline for screening and diagnosis of type 2 diabetes: a position statement from the Brazilian Diabetes Society

被引:0
|
作者
Rodacki, Melanie [1 ]
Zajdenverg, Lenita [1 ]
da Silva Jr, Wellington Santana [2 ]
Giacaglia, Luciano [3 ]
Negrato, Carlos Antonio [4 ]
Cobas, Roberta Arnoldi [5 ]
de Almeida-Pititto, Bianca [6 ]
Bertoluci, Marcello Casaccia [7 ]
机构
[1] Univ Fed Rio De Janeiro, Dept Clin Med Nutrol, Rio De Janeiro, Brazil
[2] Univ Fed Maranhao, Dept Med 1, Disciplina Endocrinol, Sao Luis, Brazil
[3] Univ Sao Paulo, Hosp Clin, Fac Med, Sao Paulo, Brazil
[4] Univ Sao Paulo, Fac Med Bauru, Bauru, Brazil
[5] Univ Estado Rio De Janeiro, Fac Ciencias Med, Dept Med Interna, Rio De Janeiro, Brazil
[6] Univ Fed Sao Paulo, Dept Med Prevent, Escola Paulista Med, Sao Paulo, Brazil
[7] Univ Fed Rio Grande do Sul, Serv Endocrinol Hosp Clin Porto Alegre, Fac Med, Porto Alegre, Brazil
来源
DIABETOLOGY & METABOLIC SYNDROME | 2025年 / 17卷 / 01期
关键词
Practice guidelines: type 2 diabetes mellitus; Prediabetic state; Blood glucose; Glycated hemoglobin; Oral glucose tolerance test; Diagnosis; Early diagnosis; Disease prevention; FASTING PLASMA-GLUCOSE; GLYCATED HEMOGLOBIN; CARDIOVASCULAR RISK; METABOLIC SYNDROME; OBESE CHILDREN; TOLERANCE TEST; LIFE-STYLE; FOLLOW-UP; OGTT; PREVALENCE;
D O I
10.1186/s13098-024-01572-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Patients with type 2 diabetes (T2D) often experience prolonged periods of asymptomatic hyperglycemia, which significantly increases the risk of developing chronic complications related to diabetes. Screening programs for individuals at high risk for T2D provide valuable opportunities not only for early diagnosis but also for detecting intermediate hyperglycemic states, commonly referred to as prediabetes. Interventions aimed at preventing diabetes in this group can successfully delay or even avoid the onset of the disease and its associated burdens. This review is an update of the Brazilian Diabetes Society (Sociedade Brasileira de Diabetes [SBD]) evidence-based guideline for diagnosing diabetes and screening T2D. Methods The methodology was previously published and defined by the internal institutional steering committee. The working group drafted the manuscript by selecting vital clinical questions for a narrative review, utilizing MEDLINE via PubMed to identify relevant studies. The review assessed the best available evidence, including randomized clinical trials (RCTs), meta-analyses, and high-quality observational studies related to the diagnosis of diabetes. Results and conclusions Fifteen specific recommendations were formulated. Screening is recommended for adults aged 35 and older or younger individuals with obesity and additional risk factors. For children and adolescents, screening is recommended starting at age ten or the onset of puberty if they are overweight or obese and have additional risk factors. Fasting plasma glucose (FPG) and HbA1c are recommended as initial screening tests. The oral glucose tolerance test (OGTT) is recommended for high-risk individuals with normal HbA1c and FPG or those with prediabetes. The 1-h OGTT is preferred over the 2-h OGTT, as it is both more practical and a superior test. A structured approach to reevaluation intervals is provided.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Drug interactions in Brazilian type 2 diabetes patients
    Moura de Araujo, Marcio Flavio
    dos Santos Alves, Priscila de Jesus
    Veras, Vivian Saraiva
    de Araujo, Thiago Moura
    Zanetti, Maria Lucia
    Coelho Damasceno, Marta Maria
    INTERNATIONAL JOURNAL OF NURSING PRACTICE, 2013, 19 (04) : 423 - 430
  • [22] Using trend arrows in continuous glucose monitoring systems for insulin adjustment in clinical practice: Brazilian Diabetes Society Position Statement
    M. Rodacki
    L. E. Calliari
    A. C. Ramalho
    A. G. D. Vianna
    D. R. Franco
    K. F. S. Melo
    L. R. Araujo
    M. Krakauer
    M. Scharf
    W. Minicucci
    R. Ziegler
    M. Gabbay
    Diabetology & Metabolic Syndrome, 13
  • [23] Using trend arrows in continuous glucose monitoring systems for insulin adjustment in clinical practice: Brazilian Diabetes Society Position Statement
    Rodacki, M.
    Calliari, L. E.
    Ramalho, A. C.
    Vianna, A. G. D.
    Franco, D. R.
    Melo, K. F. S.
    Araujo, L. R.
    Krakauer, M.
    Scharf, M.
    Minicucci, W.
    Ziegler, R.
    Gabbay, M.
    DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01):
  • [24] Diabetes and hypertension. Australian Diabetes Society position statement - Reply
    Gilbert, R
    Cooper, ME
    MEDICAL JOURNAL OF AUSTRALIA, 1996, 164 (09) : 572 - 572
  • [25] The lower limb in people with diabetes - Position statement of the Australian Diabetes Society
    Campbell, LV
    Graham, AR
    Kidd, RM
    Molloy, HF
    O'Rourke, SR
    Colagiuri, S
    MEDICAL JOURNAL OF AUSTRALIA, 2000, 173 (07) : 369 - 372
  • [26] DIABETES AND HYPERTENSION - AUSTRALIAN-DIABETES-SOCIETY POSITION-STATEMENT
    GILBERT, RE
    JASIK, M
    DELUISE, M
    OCALLAGHAN, CJ
    COOPER, ME
    MEDICAL JOURNAL OF AUSTRALIA, 1995, 163 (07) : 372 - 375
  • [27] Rationale and design of the Brazilian diabetes study: a prospective cohort of type 2 diabetes
    Barreto, Joaquim
    Wolf, Vaneza
    Bonilha, Isabella
    Luchiari, Beatriz
    Lima, Marcus
    Oliveira, Alessandra
    Vitte, Sofia
    Machado, Gabriela
    Cunha, Jessica
    Borges, Cynthia
    Munhoz, Daniel
    Fernandes, Vicente
    Kimura-Medorima, Sheila Tatsumi
    Breder, Ikaro
    Fernandez, Marta Duran
    Quinaglia, Thiago
    Oliveira, Rodrigo B.
    Chaves, Fernando
    Arieta, Carlos
    Guerra-Junior, Gil
    Avila, Sandra
    Nadruz, Wilson
    Carvalho, Luiz Sergio F.
    Sposito, Andrei C.
    CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (04) : 523 - 529
  • [28] 2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes
    Godoy-Matos, Amelio F.
    Valerio, Cynthia Melissa
    Silva Junior, Wellington S.
    de Araujo-Neto, Joao Marcello
    Bertoluci, Marcello Casaccia
    DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01):
  • [29] Correction: 2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction‑associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes
    Amélio F. Godoy‑Matos
    Cynthia Melissa Valério
    Wellington S. Silva Júnior
    João Marcello de Araujo‑Neto
    Marcello Casaccia Bertoluci
    Diabetology & Metabolic Syndrome, 16
  • [30] Portuguese-Brazilian evidence-based guideline on the management of hyperglycemia in type 2 diabetes mellitus
    Marcello Casaccia Bertoluci
    João Eduardo Nunes Salles
    José Silva-Nunes
    Hermelinda Cordeiro Pedrosa
    Rodrigo Oliveira Moreira
    Rui Manuel Calado da Silva Duarte
    Davide Mauricio da Costa Carvalho
    Fábio Rogério Trujilho
    João Filipe Cancela dos Santos Raposo
    Erika Bezerra Parente
    Fernando Valente
    Fábio Ferreira de Moura
    Alexandre Hohl
    Miguel Melo
    Francisco Garcia Pestana Araujo
    Rosa Maria Monteiro Castro de Araújo Principe
    Rosane Kupfer
    Adriana Costa e Forti
    Cynthia Melissa Valerio
    Hélder José Ferreira
    João Manuel Sequeira Duarte
    José Francisco Kerr Saraiva
    Melanie Rodacki
    Maria Helane Costa Gurgel Castelo
    Mariana Pereira Monteiro
    Patrícia Quadros Branco
    Pedro Manuel Patricio de Matos
    Pedro Carneiro de Melo Pereira de Magalhães
    Roberto Tadeu Barcellos Betti
    Rosângela Roginski Réa
    Thaisa Dourado Guedes Trujilho
    Lana Catani Ferreira Pinto
    Cristiane Bauermann Leitão
    Diabetology & Metabolic Syndrome, 12